Quick Answer
Alto Neuroscience, Inc. reported Long Term Debt of $16.17 million for the year ending 2025.
- Alto Neuroscience, Inc. showed an increase of +57.7% in Long Term Debt from 2024 to 2025.
- This data is from Alto Neuroscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $8.81 million | Q2 2024: $7.74 million | Q3 2024: $6.63 million | Q1 2025: $19.94 million | Q2 2025: $20.12 million | Q3 2025: $20.31 million.
- Over the full 3 years of available data (2023 to 2025), Alto Neuroscience, Inc.'s Long Term Debt has grown by 64.0%.
- Historical annual values: Fiscal year 2025: $16.17 million | Fiscal year 2024: $10.25 million | Fiscal year 2023: $9.86 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: